LHRH receptor targeted therapy for breast cancer

Advances in Experimental Medicine and Biology

Volumn 614, Issue , 2008, Pages 285-296

  Kakar, S S ^a   Jin, H ^b   Hong, B ^b   Eaton, J W ^a   Kang, Kyung A ^b  

^a University of Louisville School of Medicine   (United States)

^b University of Louisville

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GOLD NANOPARTICLE; GONADORELIN RECEPTOR; IRON; MAGNETITE; TRIPTORELIN;

APOPTOSIS; BREAST CANCER; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84934436188     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74911-2_32     Document Type: Conference Paper

References (19)

1. A. Jemal, R. Siegel, E. Ward et al. Cancer statistics, 2006. CA: a Cancer J Clin 2006; 56(2): 106-130
2. A.M. Bajo, A.V. Schally, G, Halmos et al. Targeted doxorubicin containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers. Clin Cancer Res 2003; 9: 3742-3748
3. S.S. Kakar, M.T. Malik, S.J. Winters et al. Gonadotropin-releasing hormone receptors: structure, expression, and signaling transduction. Vit Horm 2004; 69: 151-207
4. A. Nagy, A.V. Schally. Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers. Biol Reprod 2005; 73(5): 851-859
5. S.S. Dharap, Y. Wang, P. Chandna et al. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Nat Acad Sci USA 2005; 102(36): 12962-12967
6. J. Zhou, C. Leuschner, C. Kumar et al. Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 2006; 27(9): 2001-2008
7. C. Leuschner, C. Kumar, M. Urbina et al. The use of ligand conjugated supermagnetic iron oxide nanoparticles (SPION) for early detection of metastasis. In INST Naotech Tech Proc 1005; 1: 5-6
8. M. Islam, L. Fu, M. Su et al. Novel one-step synthesis of amine-stabilized aqueous colloidal gold nanoparticles. J Material Chem 2004; 14; 1795-1797
9. S.S. Kakar, L.C. Musgrove, D.C. Dever et al. Cloning, sequencing, and expression of human gonadotropin-releasing hormone (GnRH) receptor, Biochem Biophys Res Commun 1992; 189: 289-295
10. S.S. Kakar, S.J. Winters, W. Zacharias et al. Identification of distinct gene expression profiles associated with treatment of LbetaT2 cells with gonadotropin-releasing hormone agonist using microarray analysis. Gene 2003; 308: 67-77
11. P. Thomas, P.L. Mellon, J. Turgeon et al. The L beta T2 clonal gonadotrope: a model for single cell studies of endocrine cell secretion. Endocrinology 1996; 137: 2979-2989
12. G.Y. Bedecarrats, K.D. Linher, J.A. Janovick et al. Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function. Mol Cell Endocrin 2003; 205(1-2), 51-64
13. A. Mangia, S. Tommasi, S.J. Reshkin et al. Gonadotropin releasing hormone receptor expression in primary breast cancer: comparison of imunohistochemical, radioligand and Western blot analyses, Oncol Rep 2002; 9(5): 1127-1132
14. T. Moriya, T. Suzuki, M. Pilichowska et al. Immunohistochemical expression of gonadotropin releasing hormone receptor in human breast carcinoma. Pathol Int 2001; 51(5): 333-337
15. M. W. Qian, J.W. Eaton. Iron translocation by free fatty acids, Am J Path 1991; 139(6): 1425-1434
16. S.S. Kakar. Inhibition of growth and proliferation of EcRG293 cell line expressing highaffinity Gonadotropin-releasing hormone (GnRH) receptor under the control of an inducible promoter by GnRH agonist (D-Lys6)GnRH and antagonist (Antide). Cancer Res 1998; 58(20): 4558-4560
17. Z. Yu, H.L. Persson, J.W. Eaton et al. Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Rad Biol Med 2003; 34(10): 1243-1252
18. H.L. Persson, Z. Yu, O. Tirosh et al. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Rad Biol Med 2004; 34(10): 1295-1305
19. U.T. Brunk, J. Neuzil, J.W. Eaton. Lysosomal involvement in apoptosis, Redox Rep 2001; 6(2): 91-97